CS logo
small CS logo
Cardiovascular Research, Karolinska Institue

Stockholm, Sweden

About Cardiovascular Research, Karolinska Institue


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
2
Total Rows: 1

Clinical Trials at Cardiovascular Research, Karolinska Institue


During the past decade, Cardiovascular Research, Karolinska Institue conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
2006-06-01
2009-01-01
Completed
352
DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension
2006-09-01
2010-04-01
Terminated
282

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsGilead Sciences: 2Gilead Sciences: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Cardiovascular Research, Karolinska Institue


According to Clinical.Site data, the most researched conditions in "Cardiovascular Research, Karolinska Institue" are "Hypertension" (2 trials). Many other conditions were trialed in "Cardiovascular Research, Karolinska Institue" in a lesser frequency.

Clinical Trials Intervention Types at Cardiovascular Research, Karolinska Institue


Most popular intervention types in "Cardiovascular Research, Karolinska Institue" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Darusentan" (2 trials) and "Darusentan Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Cardiovascular Research, Karolinska Institue


The vast majority of trials in "Cardiovascular Research, Karolinska Institue" are 2 trials for "All" genders.

Clinical Trials Status at Cardiovascular Research, Karolinska Institue


Currently, there are NaN active trials in "Cardiovascular Research, Karolinska Institue". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cardiovascular Research, Karolinska Institue, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cardiovascular Research, Karolinska Institue, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 1Completed: 1Terminated: 1Terminated: 1